Description
CHEMISTRY CPT
First action · last action
2017-11-30 · 2018-10-29
Transactions
3
First transaction's obligation
$3,077,230
Base + all options value (sum of deltas)
$5,530,266
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25517A0026
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-11-30+$3,077,230= $3,077,230
- Mod P000012018-07-06+$208,855= $3,286,085
- Mod P000022018-10-29-$136,501= $3,149,585
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-11-30 | +$3,077,230 | $3,077,230 | CHEMISTRY CPT |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-07-06 | +$208,855 | $3,286,085 | CHEMISTRY CPT |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-29 | −$136,501 | $3,149,585 | CHEMISTRY CPT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6640 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526A0038 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0419 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $206,949 | FY2026 |
| 36C25526N0379 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $671,956 | FY2026 |
| 36C25526P0266 | CELLULAR TECHNOLOGY LIMITED | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $47,525 | FY2026 |
| 36C25526N0349 | QIAGEN, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $93,253 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25518N0548_3600_VA25517A0026_3600 · retrieved 2026-09-26.